Edgewood Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.88M Hold
27,837
0.03% 39
2025
Q4
$3.42M Hold
27,837
0.02% 44
2025
Q3
$3.09M Sell
27,837
-9,699
-26% -$1.1M 0.01% 43
2025
Q2
$4.16M Sell
37,536
-2,394
-6% -$255K 0.01% 40
2025
Q1
$4.47M Hold
39,930
0.02% 41
2024
Q4
$3.69M Hold
39,930
0.01% 45
2024
Q3
$3.35M Sell
39,930
-1,085
-3% -$82.8K 0.01% 42
2024
Q2
$2.81M Sell
41,015
-2,666
-6% -$178K 0.01% 45
2024
Q1
$3.2M Sell
43,681
-1,900
-4% -$146K 0.01% 42
2023
Q4
$3.69M Hold
45,581
0.01% 40
2023
Q3
$3.42M Hold
45,581
0.01% 39
2023
Q2
$3.51M Hold
45,581
0.01% 38
2023
Q1
$3.78M Sell
45,581
-39,000
-46% -$3.23M 0.01% 38
2022
Q4
$7.26M Sell
84,581
-1,294
-2% -$102K 0.03% 31
2022
Q3
$5.3M Hold
85,875
0.02% 33
2022
Q2
$5.31M Sell
85,875
-173
-0.2% -$10.7K 0.02% 36
2022
Q1
$5.12M Hold
86,048
0.01% 34
2021
Q4
$6.25M Sell
86,048
-4,459
-5% -$307K 0.01% 33
2021
Q3
$6.32M Sell
90,507
-515
-0.6% -$36.2K 0.01% 31
2021
Q2
$6.27M Hold
91,022
0.01% 32
2021
Q1
$5.88M Sell
91,022
-986
-1% -$63.6K 0.01% 32
2020
Q4
$5.36M Sell
92,008
-1,000
-1% -$60.3K 0.01% 30
2020
Q3
$5.88M Sell
93,008
-14,274
-13% -$990K 0.01% 31
2020
Q2
$8.25M Sell
107,282
-239
-0.2% -$18.3K 0.02% 28
2020
Q1
$8.04M Buy
107,521
+447
+0.4% +$30.9K 0.03% 28
2019
Q4
$6.96M Buy
107,074
+13,732
+15% +$894K 0.02% 31
2019
Q3
$5.92M Sell
93,342
-1,243
-1% -$81.3K 0.02% 30
2019
Q2
$6.39M Sell
94,585
-39,925
-30% -$2.63M 0.02% 29
2019
Q1
$8.74M Sell
134,510
-48,843
-27% -$3.25M 0.03% 27
2018
Q4
$11.5M Sell
183,353
-10,597
-5% -$741K 0.05% 28
2018
Q3
$15M Sell
193,950
-3,624
-2% -$274K 0.05% 26
2018
Q2
$14M Sell
197,574
-11,487
-5% -$811K 0.05% 26
2018
Q1
$15.8M Sell
209,061
-47
-0% -$3.74K 0.06% 26
2017
Q4
$15M Sell
209,108
-2,234
-1% -$170K 0.07% 26
2017
Q3
$17.1M Sell
211,342
-3,082
-1% -$236K 0.08% 26
2017
Q2
$15.2M Buy
214,424
+22,796
+12% +$1.52M 0.07% 26
2017
Q1
$13M Sell
191,628
-6,556
-3% -$461K 0.07% 26
2016
Q4
$14.2M Sell
198,184
-5,763,139
-97% -$428M 0.09% 26
2016
Q3
$472M Buy
5,961,323
+136,461
+2% +$11.1M 3.1% 19
2016
Q2
$486M Sell
5,824,862
-46,077
-0.8% -$4.09M 3.56% 18
2016
Q1
$539M Buy
5,870,939
+301,813
+5% +$27.2M 3.88% 16
2015
Q4
$564M Sell
5,569,126
-2,323,566
-29% -$242M 4.18% 13
2015
Q3
$775M Buy
7,892,692
+209,228
+3% +$23.2M 6.54% 2
2015
Q2
$900M Sell
7,683,464
-265,365
-3% -$29M 7.48% 2
2015
Q1
$780M Buy
7,948,829
+705,098
+10% +$71.6M 6.99% 2
2014
Q4
$683M Buy
7,243,731
+270,344
+4% +$28M 6.28% 2
2014
Q3
$742M Sell
6,973,387
-926,655
-12% -$90.7M 7.45% 2
2014
Q2
$655M Sell
7,900,042
-963,687
-11% -$75M 6.64% 2
2014
Q1
$628M Buy
8,863,729
+29,093
+0.3% +$2.28M 6.69% 1
2013
Q4
$663M Sell
8,834,636
-118,897
-1% -$8.28M 7.42% 1
2013
Q3
$563M Buy
8,953,533
+1,035,360
+13% +$61.9M 7.04% 2
2013
Q2
$406M Buy
+7,918,173
New +$413M 5.46% 6

Other funds holding GILD

Edgewood Management's GILD Position: Q1 2026 in Review

Edgewood Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 27,837 shares worth $3.88M. The position accounts for 0.03% of the portfolio, ranked #39.

Edgewood Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $900M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Edgewood Management held 27,837 shares of Gilead Sciences worth $3.88M as of Q1 2026.
  • Edgewood Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.03% of Edgewood Management's portfolio in Q1 2026, its #39 holding.
  • Edgewood Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Edgewood Management's Gilead Sciences position peaked at $900M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Edgewood Management's 13F filing for Q1 2026, filed 14 May 2026.